The DOI matches its Crossref record.
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life
Abstract
Nitric oxide (NO), which accounts for the biological properties of endothelium-derived relaxing factor, is generated by NO synthase (NOS). The vascular endothelium contains two types of NOS: one is constitutively expressed (cNOS), and the other is inducible. Endothelium-mediated vasorelaxation is impaired in atherosclerotic vessels. To determine whether tumor necrosis factor (TNF)-alpha, which is commonly found in atherosclerotic lesions, has an effect on NOS message, we measured cNOS mRNA levels in TNF-treated human umbilical vein endothelial cells (HUVECs) by RNA blot analysis with a cNOS cDNA probe. TNF-alpha markedly reduced cNOS mRNA levels in HUVECs in a dose- and time-dependent manner. In response to 3 ng/mL TNF-alpha, cNOS mRNA levels began to decrease at 4 hours and diminished to only 5% of control levels at 24 hours. As little as 0.1 ng/mL TNF-alpha reduced cNOS mRNA levels by 50%. This reduction in cNOS message in response to TNF-alpha depended on protein synthesis as it was blocked by cycloheximide. In nuclear runoff experiments, TNF-alpha did not change the rate of cNOS gene transcription. cNOS mRNA is very stable under basal conditions, with a half-life of 48 hours; however, treatment with TNF-alpha shortened this half-life to 3 hours. TNF-alpha thus appears to decrease cNOS mRNA levels by increasing the rate of mRNA degradation. TNF-induced reductions in cNOS mRNA levels may have an important effect on impaired endothelium-mediated vasorelaxation in atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“was shown to downregulate NOS3 expression and abundance [123, 131-134] by decreasing the stability of NOS3 mRNA [135, 136], effectively shortening its half-life [137].”
From Regulation of obesity and insulin resistance by nitric oxide (2014) · cites this paper as [137]
Citations
Cited by
Sorted by citations
Items 201–300 of 775
The metabolic syndrome: metabolic changes with vascular consequences
Wassink, A. M. J., Olijhoek, J. K., & Visseren, F. L. J. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01755.x · Cited by 99
Arenas, I. A., Armstrong, S. J., Xu, Y., & Davidge, S. T. (2005) · Hypertension · doi:10.1161/01.hyp.0000168925.98963.ef · Cited by 99
Role of NO in vascular smooth muscle and cardiac muscle function
Schulz, R., & Triggle, C. R. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90321-2 · Cited by 98
de Belder, A. J., Radomski, M. W., Why, H., et al. (1995) · Heart · doi:10.1136/hrt.74.4.426 · Cited by 97
Free radicals, diabetes and endothelial dysfunction
Bayraktutan, U. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00184.x · Cited by 96
The role of insulin and the adipocytokines in regulation of vascular endothelial function
Ritchie, S. A., Ewart, M., Perry, C. G., Connell, J., & Salt, I. P. (2004) · Clinical Science · doi:10.1042/cs20040190 · Cited by 98
Kessler, P., Popp, R., Busse, R., et al. (1999) · Circulation · doi:10.1161/01.cir.99.14.1878 · Cited by 94
Tran, V., Silva, T. M. D., Sobey, C. G., Lim, K., Drummond, G. R., Vinh, A., & Jelinic, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00148 · Cited by 94
Regulation of endothelial nitric oxide synthase gene expression by oxidized linoleic acid
Ramasamy, S., Parthasarathy, S., & Harrison, D. G. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33888-8 · Cited by 92
Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs
Avouac, J., & Allanore, Y. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.7.1121 · Cited by 93
“Some effects of TNFα are also mediated by the induction of a state consistent with oxidative stress [17] with impairment of nitric oxide bioavailability [18] .”
BackgroundFeng, Q. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00242-3 · Cited by 91
Crabos, M., Coste, P., Paccalin, M., et al. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0251 · Cited by 92
Functional role of NF-κB in expression of human endothelial nitric oxide synthase
Lee, K., Kim, J., Kwak, S.-N., Lee, K.-S., Lee, D.-K., Ha, K., Won, M., Jeoung, D., Lee, H., Kwon, Y., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.079 · Cited by 92
Orshal, J. M., & Khalil, R. A. (2004) · Hypertension · doi:10.1161/01.hyp.0000113044.46326.98 · Cited by 91
Fichtlscherer, S., Breuer, S., Schächinger, V., Dimmeler, S., & Zeiher, A. M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.026 · Cited by 90
An imbalance in serum concentrations of inflammatory and anti-inflammatory cytokines in hypertension
Mirhafez, S. R., Mohebati, M., Disfani, M. F., Karimian, M. S., Ebrahimi, M., Avan, A., Eslami, S., Pasdar, A., Rooki, H., Esmaily, H., et al. (2014) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2014.05.007 · Cited by 89
Expression and Expressional Control of Nitric Oxide Synthases in Various Cell Types
Förstermann, U., Kleinert, H., Gath, I., Schwarz, P., Closs, E. I., & Dun, N. J. (1995) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61085-6 · Cited by 88
Stat3 Mediates Interelukin-6 Inhibition of Human Endothelial Nitric-oxide Synthase Expression
Saura, M., Zaragoza, C., Bao, C., Herránz, B., Rodrı́guez-Puyol, M., & Lowenstein, C. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606279200 · Cited by 90
Ribeiro, A. M. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00267-4 · Cited by 86
The Ovarian Hyperstimulation Syndrome
Blumenfeld, Z. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.01.018 · Cited by 88
Emerging Role for TNF-α in Erectile Dysfunction
Carneiro, F. S., Webb, R. C., & Tostes, R. C. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01762.x · Cited by 88
“Moreover, TNF-α suppresses eNOS expression by inhibiting the gene promoter activity [66,67], predominantly through destabilization of eNOS mRNA in endothelial cells [68].”
BackgroundMartens, F. M. A. C., Rabelink, T. J., Roodt, J. O. ’., de Koning, E. J. P., & Visseren, F. L. J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl079 · Cited by 88
Kessler, P., Bauersachs, J. K., Busse, R., & Schini‐Kerth, V. B. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1746 · Cited by 87
Insulin resistance and endothelial cell dysfunction: studies in mammalian models
Kearney, M. T., Duncan, E. R., Kahn, M., & Wheatcroft, S. B. (2007) · Experimental Physiology · doi:10.1113/expphysiol.2007.039172 · Cited by 89
“…BH4, tetrahydrobiopterin; eNOS, endothelial nitric oxide synthase; Akt, protein kinase B; P, phosphorylation; and ONOO, peroxynitrite. is subject to regulation by several factors, including insulin (Kuboki et al. 2000), shear stress (Dimmeler et al. 1999) and cytokines (Yoshizumi et al. 1993).”
BackgroundNorth, A. J., Moya, F. R., Mysore, M., et al. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.13.6.7576705 · Cited by 86
Carrero, J. J., Park, S.-H., Axelsson, J., Lindholm, B., & Stenvinkel, P. (2009) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2009.00585.x · Cited by 87
“Indeed, administration of TNF-a depresses endothelium-dependent relaxation in vivo (21) while it reduces the half-life of mRNA coding for nitric oxide synthase in vitro (22).”
Cicoira, M., Bolger, A. P., Doehner, W., Rauchhaus, M., Davos, C. H., Sharma, R. K., Al-Nasser, F., Coats, A. J. S., & Anker, S. D. (2001) · Cytokine · doi:10.1006/cyto.2001.0918 · Cited by 85
Niwano, K., Arai, M., Tomaru, K., Uchiyama, T., Ohyama, Y., & Kurabayashi, M. (2003) · Circulation Research · doi:10.1161/01.res.0000091336.55487.f7 · Cited by 84
Drexler, H. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80497-4 · Cited by 84
Yoshizumi, M., Hsieh, C.-M., Zhou, F., et al. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3266 · Cited by 84
Self-citationOrshal, J. M., & Khalil, R. A. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00729.2003 · Cited by 83
Proinflammatory cytokines depress cardiac efficiency by a nitric oxide-dependent mechanism
Panas, D. L., Khadour, F., Szabó, C., & Schulz, R. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.275.3.h1016 · Cited by 83
Cytokines and natural regulators of cytokines
Bendtzen, K. (1994) · Immunology Letters · doi:10.1016/0165-2478(94)00153-7 · Cited by 82
Vignozzi, L., Filippi, S., Comeglio, P., Cellai, I., Sarchielli, E., Morelli, A., Rastrelli, G., Maneschi, E., Galli, A., Vannelli, G. B., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.01.014 · Cited by 81
“Interest-ingly, in endothelial cells TNF a directly suppressed eNOS expression by inhibiting either its gene promoter activity (Anderson and Rahmutula, 2004) or its mRNA stability (Yoshizumi et al., 1993).”
Obesity, aerobic exercise, and vascular disease: the role of oxidant stress.
Fenster, C., Weinsier, R., Darley-Usmar, V., & Patel, R. (2002) · Obesity Research · doi:10.1038/oby.2002.131 · Cited by 84
Qu, X.-W., WANG, H., Plaen, I. G. D., Rozenfeld, R. A., & Hsueh, W. (2001) · The FASEB Journal · doi:10.1096/fj.99-0343com · Cited by 81
“Indeed, many inflammatory mediators, such as LPS, TNF, and IFN-g, have been found to suppress the expression (43, 44) or the activity (12, 45, 46) of cNOS.”
BackgroundMohamed, F., Monge, J. C., Gordon, A. E., Černáček, P., Blais, D., & Stewart, D. J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.1.52 · Cited by 80
Transcriptional Induction of Endothelial Nitric Oxide Gene by Cyclosporine A
Navarro-Antolı́n, J., Rey-Campos, J., & Lamas, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3075 · Cited by 80
Reiling, N., Kröncke, R., Ulmer, A. J., Gerdes, J., Flad, H., & Hauschildt, S. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260302 · Cited by 78
Microcirculatory Dysfunction in Acute Pancreatitis
Vollmar, B., & Menger, M. D. (2003) · Pancreatology · doi:10.1159/000070727 · Cited by 78
Posttranscriptional Regulation of Endothelial Nitric Oxide Synthase During Cell Growth
Searles, C. D., Miwa, Y., Harrison, D. G., & Ramasamy, S. (1999) · Circulation Research · doi:10.1161/01.res.85.7.588 · Cited by 78
COMPARISON OF BLADDER BLOOD FLOW IN PATIENTS WITH AND WITHOUT INTERSTITIAL CYSTITIS
Pontari, M. A., Hanno, P. M., & Ruggieri, M. R. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(05)68552-7 · Cited by 78
In vivo expression profile of an endothelial nitric oxide synthase promoter-reporter transgene
Teichert, A.-M., Miller, T. L., Tai, S. C., Wang, Y., Bei, X., Robb, G. B., Phillips, M. J., & Marsden, P. A. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.4.h1352 · Cited by 77
Expression of nitric oxide synthase in ulcerative colitis
Godkin, A. J., de Belder, A., VILLA, L., WONG, A., Beesley, J. E., Kane, S. P., & Martin, J. (1996) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1996.tb02131.x · Cited by 76
Therrien, F., Agharazii, M., Lebel, M., & Larivière, R. (2012) · American Journal of Nephrology · doi:10.1159/000340033 · Cited by 77
Romero, L. I., Zhang, D.-N., Cooke, J. P., et al. (2000) · Vascular Medicine · doi:10.1177/1358836x0000500304 · Cited by 77
Liu, S. F., Barnes, P. J., & Evans, T. W. (1997) · Critical Care Medicine · doi:10.1097/00003246-199703000-00022 · Cited by 77
Jiménez‐Altayó, F., Briones, A. M., Giraldo, J., Planas, A. M., Salaíces, M., & Vila, E. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088435 · Cited by 75
“Furthermore, TNF- impaired the stability of eNOS mRNA (Yoshizumi et al., 1993).”
Insulin resistance, lipotoxicity and endothelial dysfunction
Imrie, H., Abbas, A., & Kearney, M. T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.025 · Cited by 74
Searles, C. D., Ide, L. M., Davis, M. E., Cai, H. “., & Weber, M. (2004) · Circulation Research · doi:10.1161/01.res.0000138953.21377.80 · Cited by 74
Statin Treatment and 3′ Polyadenylation of eNOS mRNA
Kosmidou, I., Moore, J. P., Weber, M., & Searles, C. D. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.154492 · Cited by 74
Cytoskeletal Regulation of Nitric Oxide Synthase
Su, Y., Kondrikov, D., & Block, E. R. (2005) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:43:3:439 · Cited by 72
“eNOS is a very stable mRNA species with measured half-lives that, after transcriptional arrest, average 24 to 48 h (19,20).”
Saura, M., Zaragoza, C., Cao, W., Bao, C., Rodrı́guez-Puyol, M., Rodrı́guez-Puyol, D., & Lowenstein, C. J. (2002) · Circulation Research · doi:10.1161/01.res.0000040397.23817.e5 · Cited by 72
The role of cytokines in cardiac surgery
Tønnesen, E., Christensen, V. B., & Toft, P. (1996) · International Journal of Cardiology · doi:10.1016/0167-5273(96)02568-5 · Cited by 72
The hepatic circulation in health and disease: Report of a single-topic symposium
Shah, V. H., García‐Cardeña, G., Sessa, W. C., et al. (1998) · Hepatology · doi:10.1002/hep.510270141 · Cited by 71
de Frutos, T., de Miguel, L. S., Farré, J., Rivas, J. G., Romero, J., Marcos‐Alberca, P., Nuñez, A., Rico, L., & López-Farré, A. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01185-2 · Cited by 71
Moreau, K. L., Deane, K. D., Meditz, A. L., & Kohrt, W. M. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.057 · Cited by 70
Saitoh, M., Osanai, T., Kamada, T., Matsunaga, T., Ishizaka, H., Hanada, H., & Okumura, K. (2003) · Heart and Vessels · doi:10.1007/s00380-003-0715-y · Cited by 70
“TNF-α has been shown to not only upregulate iNOS mRNA expression but also downregulate endothelial NOS (eNOS) mRNA expression.(16) Recently, Ito et al.”
BackgroundKatz, S. D. (1995) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(05)80012-x · Cited by 69
Macrovascular and microvascular dysfunction in the metabolic syndrome
Czernichow, S., Greenfield, J. R., Galan, P., Jellouli, F., Safar, M. E., Blacher, J., Herçberg, S., & Levy, B. I. (2010) · Hypertension Research · doi:10.1038/hr.2009.228 · Cited by 69
Mollnau, H., Oelze, M. W., August, M., Wendt, M., Daiber, A., Schulz, E., Baldus, S. E., Kleschyov, A. L., Materne, A., Wenzel, P., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000190673.41925.9b · Cited by 68
Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice
Cheung, R., Shen, F., Phillips, J. H., McGeachy, M. J., Cua, D. J., Heyworth, P. G., & Pierce, R. H. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57682 · Cited by 71
“TNF-α is also able to terminate or dampen the signal by downregulating eNOS mRNA by shortening its halflife as a negative feedback mechanism (99).”
BackgroundRevel, A., Barak, V., Lavy, Y., et al. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58389-7 · Cited by 68
Endothelial nitric oxide synthase is downregulated during hyperdynamic sepsis
Zhou, M., Wang, P., & Chaudry, I. H. (1997) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(96)00139-0 · Cited by 68
Nitric Oxide and Bronchial Hyperresponsiveness
Nijkamp, F. P., & Folkerts, G. (2000) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8474-7_6 · Cited by 66
Nishimoto, Y., Tomida, T., Matsui, H., Ito, T., & Okumura, K. (2002) · Hypertension · doi:10.1161/01.hyp.0000024267.71656.0d · Cited by 67
Nitric oxide produced via neuronal NOS may impair vasodilatation in septic rat skeletal muscle
Gocan, N. C., Scott, J. A., & Tyml, K. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.5.h1480 · Cited by 67
“Cytokines and/or endotoxin has been shown to downregulate eNOS mRNA (24, 52), whereas the CLP model of sepsis reduced the eNOS protein level in aortic endothelial cells (53).”
BackgroundKlimek, E., Skalska, A., Kwaśny-Krochin, B., Surdacki, A., Sulicka‐Grodzicka, J., Korkosz, M., Fedak, D., Kierzkowska, I., Wizner, B., & Grodzicki, T. K. (2014) · Mediators of Inflammation · doi:10.1155/2014/681635 · Cited by 66
“TNF-α blocks the activation of endothelial NO synthase (eNOS) by interfering with the phosphorylation of protein kinaseAkt [37], diminishes eNOS expression [36], and impedes degradation of ADMA, an endogenous inhibitor of eNOS [38].”
BackgroundRecent advances in cytokines: Therapeutic implications for inflammatory bowel diseases
Bouguen, G. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i5.547 · Cited by 65
Wimalasundera, R. C., Fexby, S. E., Regan, L., et al. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705168 · Cited by 65
“In particular, it has been reported to downregulate endothelial nitric oxide synthase (eNOS) mRNA expression (Yoshizumi et al., 1993) and protein (de Frutos et al., 1999).”
BackgroundYki‐Järvinen, H., Bergholm, R., & Leirisalo-Repo, M. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.7.630 · Cited by 66
Bilsborough, W., Keen, H. I., Taylor, A. L., O’Driscoll, G., Arnolda, L., & GREEN, D. J. (2006) · Rheumatology International · doi:10.1007/s00296-006-0147-y · Cited by 64
Vasospasm in Cerebral Inflammation
Eisenhut, M. (2014) · International Journal of Inflammation · doi:10.1155/2014/509707 · Cited by 65
“Endothelial NO synthase is downregulated by TNF and NO by a negative-feedback mechanism [52, 53].”
BackgroundCirculating Endothelial Progenitor Cells During Normal Pregnancy and Pre‐Eclampsia
Matsubara, K., Abe, E., Matsubara, Y., Kameda, K., & Ito, M. (2006) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2006.00387.x · Cited by 65
Two-way arginine transport in human endothelial cells: TNF-α stimulation is restricted to system y+
Sala, R., Rotoli, B. M., Colla, E., et al. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2002.282.1.c134 · Cited by 64
Sacchi, A., Gasparri, A. M., Curnis, F., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1445 · Cited by 64
“For instance, TNF can induce on endothelial cells leukocyte adhesion molecules (45, 46), proinflammatory cytokines (47, 48), fibrin deposition (13, 49), nitric oxide production (50, 51), and apoptosis (31).”
BackgroundThe Roles of Neutrophils Linking Periodontitis and Atherosclerotic Cardiovascular Diseases
Irwandi, R. A., Chiesa, S. T., Hajishengallis, G., Papayannopoulos, V., Deanfield, J. E., & D’Aiuto, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.915081 · Cited by 70
Psoriasis and Cardiometabolic Diseases: Shared Genetic and Molecular Pathways
Piaserico, S., Orlando, G., & Messina, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169063 · Cited by 71
Functional Inhibition of Constitutive Nitric Oxide Synthase in a Rat Model of Sepsis
Scott, J. A., Mehta, S., Duggan, M., Bihari, A., & McCormack, D. G. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2011144 · Cited by 62
Endothelial Cell Dysfunction and Abnormal Tissue Perfusion
Vallet, B., Wiel, É., & Rodie-Talbère, P.-A. (2002) · Update in intensive care and emergency medicine · doi:10.1007/978-3-642-56107-8_12 · Cited by 63
Davis, J. R., Giardina, J. B., Green, G. M., et al. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00270.2001 · Cited by 63
Najarian, T., Marrache, A. M., Dumont, I. J., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1149 · Cited by 63
Cytokines and autoantibodies to cytokines
Bendtzen, K., Hansen, M., Ross, C., Poulsen, L. K., & Svenson, M. (1995) · Stem Cells · doi:10.1002/stem.5530130303 · Cited by 62
Laumonnier, Y., Nadaud, S., Agrapart, M., & Soubrier, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004696200 · Cited by 62
REGULATION OF EXPRESSION OF THE ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE
Harrison, D. G., Sayegh, H. S., Ohara, Y., Inoue, N., & Venema, R. C. (1996) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1996.tb02606.x · Cited by 62
Piaserico, S., Osto, E., Famoso, G., Zanetti, I., Gregori, D., Poretto, A., Iliceto, S., Peserico, A., & Tona, F. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.05.036 · Cited by 62
Ballermann, B. J. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00943.x · Cited by 61
Endogenous Nitric Oxide in Cardiovascular Disease and Transplantation
Dusting, G. J., & Macdonald, P. S. (1995) · Annals of Medicine · doi:10.3109/07853899509002593 · Cited by 61
Cerebral blood perfusion changes in multiple sclerosis
Wuerfel, J. T., Paul, F., & Zipp, F. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.02.011 · Cited by 61
“release by destabilizing eNOS transcripts [47] and by reducing protein kinase B mediated phosphorylation of eNOS [48].”
Gevaert, A. B., Lemmens, K., Vrints, C. J., & Craenenbroeck, E. M. V. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4865756 · Cited by 60
“HFpEF itself causes a systemic inflammatory state with high levels of circulating proinflammatory cytokines, increasing production of reactive oxygen species and exerting direct deleterious effects on eNOS expression [42, 43].”
BackgroundGiardina, J. B., Green, G. M., Cockrell, K. L., Granger, J. P., & Khalil, R. A. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00704.2001 · Cited by 60
Kalinowski, L., Janaszak‐Jasiecka, A., Siekierzycka, A., Bartoszewska, S., Woźniak, M., Lejnowski, D., Collawn, J. F., & Bartoszewski, R. (2016) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-016-0017-x · Cited by 63
Arenas, I. A., Xu, Y., & Davidge, S. T. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00990.2005 · Cited by 59
“TNF- reduces NO availability by decreasing eNOS expression (39) or by increasing NO inactivation by superoxide anion through stimulation of NAD(P)H oxidase (20).”
BackgroundHo, J. J. D., Robb, G. B., Tai, S. C., Turgeon, P. J., Mawji, I. A., Man, H. S. J., & Marsden, P. A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01257-12 · Cited by 59
“In addition, models of proliferation/injury (12), tumor necrosis factor alpha (TNF- ) treatment (13, 14), and exposure to lipopolysaccharide (15) or high levels of oxidized low-density lipoprotein (16) all”
BackgroundEffect of clopidogrel on the expression of inflammatory markers in rabbit ischemic coronary artery
Molero, L., López-Farré, A. J., Mateos‐Cáceres, P. J., Fernández‐Sánchez, R., Maestro, M. L., Silva, J., Rodríguez, E., & Macaya, C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706340 · Cited by 58
“The expression of eNOS protein is downregulated under inflammatory condi- tions, which has been associated with endothelial dysfunction (Yoshizumi et al., 1993).”
BackgroundPriming of polymorphonuclear leukocytes: a culprit in the initiation of endothelial cell injury
Jacobi, J. M., Sela, S., Cohen, H. I., Chezar, J., & Kristal, B. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01040.2005 · Cited by 58
“Inflammatory mediators and/or ROS released from primed PMNL can be responsible for the reduction in eNOS mRNA, as found by us and others (18, 48).”
BackgroundNitric oxide and hypercholesterolemia: a matter of oxidation and reduction?
Wever, R. M. F., Stroes, E. S. G., & Rabelink, T. J. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00304-3 · Cited by 59
“Interestingly, chronic stimulation of human umbilical vein endothelial cells with inflammatory cytokines, such as IFN-g, TNF or IL-1, resulted in a profound reduction of NOS-III transcription, thereby, reducing NOS-III expression in endothelial cells [92,93].”
BackgroundVanderheyden, M. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0828 · Cited by 57
“…Pro-inflammatory cytokine levels and hyperaemic brachial artery diameters were obtained shortly after admission for an episode of acute heart failure and 11&3 days later at the time of recompensation, which was obtained using diuretic therapy without changing other cardiovascular medications.”
MethodBelhassen, L., Kelly, R. A., Smith, T. W., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118622 · Cited by 58
“NOS3 mRNA levels and activity in large vessel endothelial cells are known to be increased by shear stress (12) and decreased by inflammatory cytokines (3, 13).”
BackgroundStriking crosstalk of ROCK signaling with endothelial function
Noma, K., Kihara, Y., & Higashi, Y. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.03.005 · Cited by 57
Metadata
- Authors
- Yoshizumi, M., Perrella, M. A., Burnett, J. C., & Lee, M. E.
- Affiliations
- Harvard University (US)
- Venue
- Circulation Research
- Published
- 1993-07
- Volume
- 73
- Issue
- 1
- Pages
- 205-209
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2145570729
- Cited by
- 771
- References
- 0
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 9 · 2023: 10 · 2022: 13 · 2021: 15 · 2020: 16 · 2019: 12 · 2018: 16 · 2017: 14 · 2016: 11 · 2015: 17 · 2014: 35 · 2013: 19 · 2012: 18
- FWCI
- 21.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- TNF-α, endothelial nitric oxide synthase, constitutive nitric oxide synthase, mRNA stability, mRNA degradation, human umbilical vein endothelial cells, atherosclerosis, cycloheximide, gene transcription
- MeSH terms
- Amino Acid Oxidoreductases, Base Sequence, Endothelium, Vascular, Half-Life, Humans, Molecular Sequence Data, RNA, Messenger, Transcription, Genetic, Tumor Necrosis Factor-alpha, Umbilical Veins, Down-Regulation, Polymerase Chain Reaction, Nitric Oxide Synthase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review